Posaconazole and risk of cutaneous squamous cell carcinoma after lung transplantation: a single institution, retrospective cohort study

By sjmartinez • August 10, 2023

Kuklinski LF, Klomhaus AM, Shen A, Achamallah N, Soriano TT, Saggar R, Weigt SS. Posaconazole and risk of cutaneous squamous cell carcinoma after lung transplantation: a single institution, retrospective cohort study. Arch Dermatol Res. 2023 Aug 9. doi: 10.1007/s00403-023-02699-y. Epub ahead of print. PMID: 37558828.

Tags: antifungal, Dermatology, General Internal Medicine, immunosuppression, Keratinocyte cancer, Lung transplant, posaconazole, Publications, Pulmonary, Critical Care & Sleep Medicine, squamous cell carcinoma

Immune activation and glycolytic responses to Cutibacterium acnes cell wall polysaccharides

Qin M, Evron E, Tran PT, Deng M, Nelson AM, Kim J, Agak GW. Immune activation and glycolytic responses to Cutibacterium acnes cell wall polysaccharides.[...]

Frailty in lung transplant recipients is associated with anemia and telomere dysfunction but independent of epigenetic age

Kapse B, Mohanty RP, Wax M, Gao Y, Tran L, Wolters PJ, Pellegrini M, Singer JP, Greenland JR. Frailty in lung transplant recipients is associated[...]

Toxic Epidermal Necrolysis-Like Acute Cutaneous Lupus Erythematosus Following an Upper Respiratory Infection

Yan MJ, Phan H, Hsu S, Kang Y, Yu Y. Toxic Epidermal Necrolysis-Like Acute Cutaneous Lupus Erythematosus Following an Upper Respiratory Infection. Cureus. 2025 Apr[...]